beth
JF-Expert Member
- Aug 19, 2012
- 3,877
- 6,326
Serikali Nchini humo imeidhinisha matumizi ya dharura ya Chanjo ya Johnson and Johnson dhidi ya Ugonjwa wa COVID-19. Hadi sasa Mamlaka za Afya za India zimeidhinisha Chanjo kadhaa ikiwemo AstraZeneca.
Taifa hilo limekuwa likirekodi wastani wa Visa vipya 30,000 hadi 40,000 kwa siku tangu mwezi Julai. Licha ya maambukizi kupungua kutoka 400,000 Serikali imeonya bado hatari ipo.
======
India has reported an average of 30,000 to 40,000 new coronavirus cases every day since July, and the federal government has warned that although cases have dipped from a high of 400,000 daily at the peak of the deadly second wave, the danger has not abated yet.
India has approved Johnson & Johnson's (JNJ.N) single-dose COVID-19 vaccine for emergency use on Saturday, health minister Mansukh Mandaviya said in a tweet.
The pharmaceutical giant had applied for emergency use approval of its vaccine, the company had said on Friday. The shot will be brought to India through a supply agreement with homegrown vaccine maker Biological E Ltd, J&J had said.
Indian health authorities have so far approved the use of vaccines developed by AstraZeneca (AZN.L), Bharat Biotech, Russia's Gamaleya Institute and Moderna (MRNA.O).
Coronavirus cases worldwide surpassed 200 million earlier in the week, according to a Reuters tally, as the more-infectious Delta variant threatens areas with low vaccination rates and strains healthcare systems.
India has reported an average of 30,000 to 40,000 new coronavirus cases every day since July, and the federal government has warned that although cases have dipped from a high of 400,000 daily at the peak of the deadly second wave, the danger has not abated yet.
Source: Reuters
Taifa hilo limekuwa likirekodi wastani wa Visa vipya 30,000 hadi 40,000 kwa siku tangu mwezi Julai. Licha ya maambukizi kupungua kutoka 400,000 Serikali imeonya bado hatari ipo.
======
India has reported an average of 30,000 to 40,000 new coronavirus cases every day since July, and the federal government has warned that although cases have dipped from a high of 400,000 daily at the peak of the deadly second wave, the danger has not abated yet.
India has approved Johnson & Johnson's (JNJ.N) single-dose COVID-19 vaccine for emergency use on Saturday, health minister Mansukh Mandaviya said in a tweet.
The pharmaceutical giant had applied for emergency use approval of its vaccine, the company had said on Friday. The shot will be brought to India through a supply agreement with homegrown vaccine maker Biological E Ltd, J&J had said.
Indian health authorities have so far approved the use of vaccines developed by AstraZeneca (AZN.L), Bharat Biotech, Russia's Gamaleya Institute and Moderna (MRNA.O).
Coronavirus cases worldwide surpassed 200 million earlier in the week, according to a Reuters tally, as the more-infectious Delta variant threatens areas with low vaccination rates and strains healthcare systems.
India has reported an average of 30,000 to 40,000 new coronavirus cases every day since July, and the federal government has warned that although cases have dipped from a high of 400,000 daily at the peak of the deadly second wave, the danger has not abated yet.
Source: Reuters